Vuélvete ilimitado con Magzter GOLD

Vuélvete ilimitado con Magzter GOLD

Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo

$149.99
 
$74.99/Año

Intentar ORO - Gratis

New genes: the millionaire guinea pigs risking death to live for ever

The Observer

|

September 07, 2025

Firms offering untested 'longevity' jabs and therapies were once based in offshore free zones. Now a US state is relaxing the rules, writes Patricia Clarke

New genes: the millionaire guinea pigs risking death to live for ever

Patrick Friedman is no stranger to medical experimentation. Early last year, the American investor and grandson of the Nobel prizewinning economist Milton Friedman had all of the bacteria in his mouth replaced in an attempt to permanently prevent cavities.

He has a microchip embedded in his hand that operates as both a Tesla key and a business card.

On the Caribbean island of Roatán, Honduras, Friedman has now tested a new medicine, a single injection that promises to “increase lean muscle mass and decrease fat”, pitched as a way to slow ageing and extend a person’s healthy years - what the industry calls “longevity”.

The therapy was designed by a company called Minicircle, a startup based between the US and Honduras, where it operates outside the confines of the US Food and Drug Administration (FDA).

Friedman, speaking over Zoom, was clear this was a riskier intervention: “I was like: ‘Wow, I'm going to inject something with new DNA into my body.’ I wouldn't blame anyone else for not being comfortable with it.”

Friedman is in the vanguard of the longevity libertarians, setting up projects offshore in “free zones” in order to escape the regulation that they see not as a means of protecting people, but as a constraint on innovation and the potential of humanity.

Their pursuit of eternal life is reshaping legislation in the US, too. In May, the state of Montana broadened its right-to-try legislation, which since 2014 has allowed terminally ill patients to access treatments that have not yet gained FDA approval. Now, otherwise healthy patients will be able to apply to try unproven longevity medicines.

Proponents say it is an exciting way for private companies to carry out potentially lifesaving research at speed, bypassing an outdated and overly bureaucratic FDA. Critics say that it is only a matter of time “before something really bad happens”.

MÁS HISTORIAS DE The Observer

The Observer

Can a biopic of the Boss be anything other than blinded by his light?

Heavens above, not another biopic. I'm still in recovery from A Complete Unknown, James Mangold’s attempted unveiling of The Mysterious Soul of Bob Dylan starring Timothy Someone-or-other.

time to read

2 mins

October 26, 2025

The Observer

The Observer

Reeves is still only getting part of the Brexit message

The financial markets, and much of the media, seem obsessed by the level of public sector debt and borrowing.

time to read

3 mins

October 26, 2025

The Observer

The Observer

The anonymous Twitter troll account set up to discredit Virginia Giuffre

The online attacks came thick and fast, all 479 of them designed to discredit the accuser of Epstein, Maxwell and Prince Andrew.

time to read

5 mins

October 26, 2025

The Observer

The Observer

Badenoch and Farage should stop playground politics of making rules they can't keep

Do unto others as you would have them do unto you. That's the golden rule I remember being taught as a child in primary school. Not a bad guiding principle.

time to read

3 mins

October 26, 2025

The Observer

The Observer

Museums are in the pink while corporate sponsors remain shy

By embracing private philanthropy, the sector has received record sums, however businesses are feeling burnt by protests, write Nicole Fan and Stephen Armstrong

time to read

3 mins

October 26, 2025

The Observer

The Observer

'Democrat saviour' or 'commie bastard': Mamdani, would-be king of New York

The 34-year-old socialist set to become the Big Apple's first Muslim mayor may be the left's greatest hope - and biggest threat. Hugh Tomlinson joins the new star of US politics on the campaign trail

time to read

8 mins

October 26, 2025

The Observer

Use Russia's money

Europe has missed its chance to hit Putin's finances

time to read

2 mins

October 26, 2025

The Observer

Struggling 'clean food' brands dig in for long haul

Autumn, season of mists and mellow fruitfulness, wrote Keats. Not if you're in the plant-based food industry. Sales at major brands, including Oatly and Beyond Meat, are stalling.

time to read

2 mins

October 26, 2025

The Observer

Reeves mission: to build a European Silicon Valley centred on 'golden triangle'

Brexit is costing the UK 80bn a year in lost taxes, hitting output by up to 8% and investment by more than twice as much. The chancellor has her work cut out

time to read

5 mins

October 26, 2025

The Observer

The Observer

Academics sign letter of support after ‘vile’ abuse of Israeli professor

Tom Watson, Margaret Hodge, Michael Grade, Prof Andrew Roberts and hundreds of academics are among more than 1,600 signatories of an open letter condemning a “targeted harassment campaign” against an Israeli professor at a London university.

time to read

1 mins

October 26, 2025

Listen

Translate

Share

-
+

Change font size